Larimar Therapeutics Inc (LRMR)
2.28 x 1 2.40 x 2
Post-market by (Cboe BZX)
2.28 -0.26 (-10.24%) 03/24/25 [NASDAQ]
2.28 x 1 2.40 x 2
Post-market 2.39 +0.11 (+4.82%) 17:38 ET
for Mon, Mar 24th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Operating Expenses | 41,758 | 36,526 | 50,465 | 42,804 | 23,214 |
| Operating Income | -41,758 | -36,526 | -50,465 | -42,804 | -23,214 |
| Other Income | 4,809 | 1,171 | -171 | 322 | 82 |
| Pre-tax Income | -36,949 | -35,355 | -50,636 | -42,482 | -23,132 |
| Net Income Continuous | -36,949 | -35,355 | -50,636 | -42,482 | -23,132 |
| Net Income | $-36,949 | $-35,355 | $-50,636 | $-42,482 | $-23,132 |
| EPS Basic Total Ops | -0.84 | -1.37 | -2.95 | -3.57 | -3.80 |
| EPS Basic Continuous Ops | -0.84 | -1.37 | -2.95 | -3.58 | -3.80 |
| EPS Diluted Total Ops | -0.84 | -1.37 | -2.95 | -3.57 | -3.80 |
| EPS Diluted Continuous Ops | -0.84 | -1.37 | -2.95 | -3.58 | -3.80 |
| EPS Diluted Before Non-Recurring Items | -0.84 | -1.37 | -2.95 | -3.57 | -12.85 |
| EBITDA(a) | $-43,290 | $-36,982 | $-50,153 | $-42,639 | $-23,136 |